Ameritas Investment Company’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-242
Closed -$29.5K 1001
2021
Q1
$29.5K Buy
+242
New +$29.5K ﹤0.01% 1132